To first assess the field performance of the anti-PGL-I UCP-LFA in leprosy patients by local staff on the Comoros, leprosy patients detected during door-to-door screening or routine leprosy case detection were tested for anti-PGL-I IgM at field sites using the anti-PGL-I UCP-LFA. This evidence concerns the gene CD40LG and leprosy.